Skip to main content

Table 1 Prevalence, awareness, treatment and control of hypertension based on the JNC7 hypertension guidelinea

From: Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study

Variables Total (%) HTN Prevalenceb
(95%CI)
Awarenessc
(95%CI)
Treatmentd
(95%CI)
Controllede
(95%CI)
Total (%) 162,842(100%) 41,266(22.3) 25,788(77.5) 33.707(82.2) 18,495(75.9)
Sex male 72,861(44.74) 18.85(16.87,20.99) 60.95(55.32,66.31) 72.51(65.08,78.88) 72.17(66.44,77.26)
Female 89,981(55.26) 25.92(24.23,27.68) 83.97(80.87,86.65) 89.51(86.29,92.05) 75.84(70.77,80.27)
Age 35–39 27,440(16.85) 5.91(4.93,7.06) 45.19(39.46,51.06) 62.55(52.72,71.44) 79.58(74.57,83.82)
40–44 30,254(18.58) 10.54(8.99,12.31) 58.33(51.80,64.57) 69.79(62.68,76.06) 77.05(71.48,81.81)
45–49 29,289(17.99) 18.37(16.33,20.60) 67.92(61.81,73.48) 76.44(69.93,81.90) 75.61(70.77,79.87)
50–54 25,857(15.88) 28.39(25.44,31.53) 74.60(69.45,79.15) 82.56(77.21,86.87) 75.36(70.57,79.60)
55–59 22,980(14.11) 37.68(34.88,40.56) 78.73(75.14,81.93) 86.28(82.18,89.56) 73.71(67.49,79.11)
 > 59 27,022(16.59) 52.10(49.31,54.87) 81.55(78.88,83.95) 89.12(85.84,91.71) 73.08(67.60,77.94)
Education Illiterate 33,549(20.61) 40.84(37.07,44.72) 82.83(79.98,85.35) 88.14(84.74,90.86) 70.63(64.35,76.21)
1–5 y 51,797(31.83) 24.16(21.41,27.15) 76.15(71.66,80.13) 83.97(79.28,87.77) 75.36(70.18,78.57)
6-8y 23,053(14.16) 19.32(16.79,22.13) 68.05(61.55,73.92) 78.16(70.83,84.06) 74.34(69.25,78.84)
9-12y 34,989(21.50) 15.84(13.96,17.93) 66.26(60.45,71.62) 76.91(69.98,82.64) 77.42(72.40,81.76)
 ≥ 13 y 19,362(11.90) 15.42(13.55,17.49) 64.91(57.77,71.43) 76.65(67.26,83.98) 77.18(71.24,82.20)
Marital status Married 148,270(91.05) 21.58(19.89,23.37) 72.58(68.12,76.63) 81.45(76.14,85.80) 74.38(69.35,78.83)
Single 3416(2.10) 8.73(6.54,11.57) 42.73(35.50,50.29) 51.84(42.76,60.81) 68.29(57.90.77.13)
divorced 11,156(6.85) 39.57(37.14,42.05) 87.13(84.98,89.02) 91.58(88.66,93.80) 75.14(68.09,81.07)
Hookah No 150,107(92.18) 22.54(20.77,24.43) 74.60(70.27,78.49) 82.83(77.72,86.96) 74.54(69.23,79.20)
Yes 12,735(7.82) 20.11(17.64,22.83) 64.17(57.39,70.43) 75.35(67.77,81.63) 73.16(68.96,76.98)
Drug abuse No 146,330(89.86) 22.57(20.72,24.53) 75.19(71.01,78.94) 82.92(77.81,87.05) 74.89(69.57,79.56)
Yes 16,476(10.12) 20.51(18.72,22.42) 62.40(55.97,68.42) 76.56(69.96,82.07) 70.55(66.21,74.55)
Alcohol No 152,367(93.57) 22.70(20.98,24.52) 74.81(70.86,78.40) 83.06(78.27,86.97) 74.62(69.37,79.24)
Yes 10,435(6.41) 17.45(15.16,20.02) 56.61(47.51,65.29) 68.26(57.15,77.62) 71.01(65.02,76.35)
Smoking status No 127,431(78.25) 23.23(21.43,25.12) 76.54(72.47,80.16) 83.73(78.96,87.59) 74.26(69.9,78.91)
Current 22,928(14.08) 14.71(13.05,16.54) 60.91(52.59,68.64) 74.42(65.23,81.86) 75.77(70.32,80.49)
Former 12,483(7.67) 28.12(25.72,30.65) 64.85(60.65,68.83) 77.97(72.89,82.33) 74.68(69.75,79.05)
BMI  > 25 44,954(27.71) 12.61(11.21,14.15) 63.04(59.03,66.88) 77.39(72.01,81.99) 76.27(71.55,80.42)
25.0–29.9 66,181(40.80) 21.83(19.40,24.48) 72.32(67.72,76.48) 80.94(75.33,85.52) 75.23(69.65,80.08)
30.0–34.9 37,813(23.31) 29.57(26.85,32.45) 77.59(73.82,80.95) 84.55(79.82,88.33) 74.68(69.09,79.56)
 ≥ 35 13,261(8.18) 38.76(35.18,42.46) 81.64(78.16,84.67) 86.47(81.64,90.18) 70.34(63.67,76.24)
Economic status 1st quintile 32,562(20.05) 27.83(24.24,31.73) 76.68(72.83,80.14) 83.08(78.81,86.63) 70.41(765.09,75.23)
2nd quintile 34,543(21.27) 24.44(22.02,27.03) 75.46(71.23,79.24) 83.21(78.86,86.82) 73.39(69.26,77.15)
3rd quintile 33,404(20.56) 22.45(20.59,24.44) 74.77(70.69,78.46) 82.60(78.0,86.42) 74.74(69.04,79.70)
4th quintile 35,354(21.76) 19.53(17.47,21.78) 70.01(64.28,75.18) 80.07(73.09,85.60) 76.03(70.16,81.05)
5th quintile 26,574(16.36) 19.45(17.18,21.93) 71.72(65.46,77.24) 82.27(73.89,88.38) 77.84(71.24,83.28)
  1. aFor all calculations we used centers as the primary sampling units in the survey design and used probability weights
  2. b Prevalence rate is calculated by dividing people with HTN to the total population
  3. c Awareness is calculated by dividing people who are aware of their HTN into the total number of people with HTN
  4. dTreatment is calculated by dividing people who have received antihypertensive drugs into people who are aware of their HTN
  5. e Control is calculated by dividing people with normal HTN who have been treated with antihypertensive drugs over the total number of people treated with antihypertensive drugs